Trading Signals: BDX Stock Price Prediction and Forecast (Mon. Mar. 17, 2014 - Wed. Sep. 27, 2023)(Becton Dickinson and Company)
| BDX latest price $135.5184 (1.23%) ($134.3509 - $136.1021) on Mon. May. 4, 2015. | |
| | Trend Analysis and Forecast | | | | Average Daily Percentage Swing | 1.11% (three month average) | | RSI | 58 | | Latest Price | $135.5184(1.23%) | | Stocks Behave Similarly | Similar Stock List | | Daily Trend | BDX advances 0.3% a day on average for past five trading days. | | Weekly Trend | BDX advances 0.1% a week on average for past two weeks. | | Market Behavior | Value stock rally for large cap. Normal for small cap. | | Correlated ETFs | Broad market will support BDX advance at 0% a week (0% probability)
DIA(48%) XHB(34%) XLV(18%) IBB(16%) QQQ(15%) | | Factors Impacting BDX price | BDX will decline at least -0.555% in a week (0% probabilities).
VIXM(-7%) EMHY(-3%) UUP(-2%) SHY(-2%) GLD(-2%) | | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | | | | Relative Volatility | (options are extremely cheap) | | | | | Market Trend Strength | -0.555% (StdDev 1.11%) | | Hourly BBV | 0 () | | Intraday Trend | 0.8% | | | | | |
|
| 5 Day Moving Average | $134.15(1.02%) | | 10 Day Moving Average | $134.87(0.48%) | | 20 Day Moving Average | $134.36(0.86%) | | To recent high | -3.3% | | To recent low | 3.3% | | Market Cap | $39.283b | | | | | | |
Becton, Dickinson & Co. is a medical technology company. The firm engages in the development, manufacture and sale of medical supplies, devices, laboratory equipment and diagnostic products used by healthcare institutions, physicians, life science researchers, clinical laboratories, the pharmaceutical industry and the general public. It operates through the following segments: BD Medical, BD Life Sciences and BD Interventional. The BD Medical segment produces medical technologies and devices that are used to help improve healthcare delivery. The BD Life Sciences segment provides products for the safe collection and transport of diagnostics specimens, and instruments and reagent systems to detect infectious diseases, healthcare-associated infections and cancers. The BD Interventional segment provides vascular, urology, oncology and surgical specialty products to hospitals, individual healthcare professionals, extended care facilities, alternate site facilities, and patients via Homecare business. The company was founded in 1897 and is headquartered in Franklin Lakes, NJ. |